These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 134727)

  • 1. [General pharmacology and secretion inhibitory action of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropanium bromide-(+/-)-tropate (ipratropiumbromide) (author's transl)].
    Bauer R; Kuhn FJ; Stockhaus K; Wick H
    Arzneimittelforschung; 1976; 26(5a):974-80. PubMed ID: 134727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of (8r)-3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropaniumbromide-(+/-)-tropate ((ipratropiumbromide) on tracheobronchial spasm, bronchial and salivary secretions, ECG and heart rate (author's transl)].
    Bauer R; Püschmann S; Wick H
    Arzneimittelforschung; 1976; 26(5a):981-5. PubMed ID: 134728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxicological studies on ipratropiumbromide (author's transl)].
    Sarafana L; Clark GC; Stötzer H
    Arzneimittelforschung; 1976; 26(5a):985-9. PubMed ID: 134729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of the anticholinergic bronchospasmolytic agent flutropium bromide.
    Bauer R; Fügner A
    Arzneimittelforschung; 1986 Sep; 36(9):1348-52. PubMed ID: 2431695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacology of the bronchospasmolytic oxitropium bromide].
    Bauer VR
    Arzneimittelforschung; 1985; 35(1A):435-40. PubMed ID: 4039183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the problem of Side Effects of Anticholinergic Drugs Depending on the Route of Application/Inhalation versus intravenous injection of ipratropiumbromide].
    Bleichert A
    Arzneimittelforschung; 1976; 26(5a):1010-3. PubMed ID: 134722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ipratropium bromide on the action of bronchoactive agents.
    Kitamura S; Ishihara Y; Sugiyama Y; Izumi T; Hayashi R; Hsu LH; Kosaka K
    Arzneimittelforschung; 1982; 32(2):128-30. PubMed ID: 6461333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the action of an anticholinergic agent in combination with a tranquilizer on gastric juice secretion in man].
    Scherberger RR; Kaess H; Brückner S
    Arzneimittelforschung; 1975 Sep; 25(9):1460-3. PubMed ID: 26
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ipratropium bromide in controlled clinical trials. Short communication (II): Time-response measurements of pulmonary function after ipratropium bromide and isoprenaline].
    Strsemann E
    Arzneimittelforschung; 1976; 26(5a):1015-7. PubMed ID: 134724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the pharmacokinetics and biotransformation of ipratropium bromide in the rat and dog].
    Förster HJ; Kramer I; Pook KH; Wahl D
    Arzneimittelforschung; 1976; 26(5a):992-1005. PubMed ID: 134731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)].
    Adlung J; Höhle KD; Zeren S; Wahl D
    Arzneimittelforschung; 1976; 26(5a):1005-10. PubMed ID: 134721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticholinergic properties of oxitropium bromide (Ba 253) and its metabolites].
    Kitagawa H; Takeda F; Izumita M; Hayashi T; Kohei H
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):49-54. PubMed ID: 2524433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the pharmacology of 9,10-dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol (WA 335), a histamine and serotonin antagonist (author's transl)].
    Engelhardt G
    Arzneimittelforschung; 1975 Nov; 25(11):1723-37. PubMed ID: 1049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the cholinolytic activity of pramiverine].
    Enenkel HJ; Müller-Calgan H; Schorscher E
    Arzneimittelforschung; 1976 Apr; 26(4b):690-6. PubMed ID: 821493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)].
    Ishihara Y; Izumi T; Hayashi R; Hsu LH; Sugiyama Y; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1980 Aug; 18(8):501-5. PubMed ID: 6448308
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological activities of 1,1-diethyl-2-methyl-3-diphenylmethylenepyrrolidinium bromide (pyrodifenium bromide).
    Kumada S; Hitomi M
    Jpn J Pharmacol; 1967 Mar; 17(1):90-104. PubMed ID: 5299979
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ipratropium Bromide, an Anticholinergic Bronchodilator/Behavior of airways resistance in patients with reversible respiratory obstruction following inhalation of various doses of ipratropium bromide].
    Loddenkemper R
    Arzneimittelforschung; 1976; 26(5a):1017-20. PubMed ID: 134725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short Communication: Rotation-viscosimetric determinations of the effect of ipratropiumbromide on bronchial excretion/a double blind study].
    Stresemann E
    Arzneimittelforschung; 1976; 26(5a):1013-5. PubMed ID: 134723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of a new anticholinergic agent, 1, 1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene) piperidinium bromide (SA-504).
    Tamaki H; Tanaka M; Murata S; Harigaya S; Kiyomoto A
    Jpn J Pharmacol; 1972 Oct; 22(5):685-99. PubMed ID: 4539786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heart rate behaviour and hemodynamics after oral therapy with ipratropium bromide in patients with sinus bradycardia (author's transl)].
    Kikis D; Esser H; Heinrich K
    Arzneimittelforschung; 1981; 31(10):1751-4. PubMed ID: 6459098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.